First- and second-line treatment of metastatic pancreatic adenocarcinoma: the conundrum continues.
Philip
Philip A
PA
Professor in Medicine and Oncology, Gastrointestinal Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.